Related Experiment Video

Updated: Jul 19, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Ruboxistaurin

Christina A Taulien1, Scott V Joy

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27705-0493, USA. joy00002@mc.duke.edu

Drugs of Today (Barcelona, Spain : 1998)
|October 10, 2006
PubMed

Insights

Ruboxistaurin, a protein kinase C inhibitor, shows potential in treating diabetic microvascular complications like retinopathy and neuropathy, which are linked to type 2 diabetes.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Endocrinology

Background:

  • Overactivation of protein kinase C (PKC) is implicated in type 2 diabetes pathogenesis.
  • PKC plays a key role in microvascular complications, including retinopathy, neuropathy, and nephropathy.
  • Ruboxistaurin is a selective inhibitor of the beta isoform of PKC.

Purpose of the Study:

  • To discuss the role of PKC in diabetes-related tissue injury.
  • To review pharmacologic and clinical studies on ruboxistaurin.
  • To evaluate ruboxistaurin's potential in mitigating diabetic microvascular complications.

Main Methods:

  • Review of existing pharmacologic data.
  • Analysis of clinical trial results.
  • Discussion of PKC's role in diabetic pathology.

Main Results:

  • Ruboxistaurin demonstrates potent and specific inhibition of PKC beta isoform.
  • Evidence suggests PKC overactivation contributes to diabetic microvascular damage.
  • Studies indicate ruboxistaurin's potential therapeutic benefit.

Conclusions:

  • Ruboxistaurin is a promising therapeutic agent for diabetic microvascular complications.
  • Targeting PKC may offer a novel strategy for managing diabetes complications.
  • Further research is warranted to fully establish ruboxistaurin's efficacy.

More Related Videos

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

Related Concept Videos

Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Peroxisomes01:30

Peroxisomes

Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...